1 / 2

Dasatinib ( nM ) 0 0 0.1 0.5 1 5

250K. 200K. Dasatinib (nM) 0 0 0.5 1 5 10 M-CSF - + + + + +. 88.6. WB: Phospho- FMS Y708 WB: FMS. 150K. 100K. 50K. 0. Dasatinib (nM) 0 0 0.5 1 5 10

Download Presentation

Dasatinib ( nM ) 0 0 0.1 0.5 1 5

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 250K 200K Dasatinib (nM) 0 0 0.5 1 5 10 M-CSF - + + + + + 88.6 WB: Phospho- FMS Y708 WB: FMS 150K 100K 50K 0 Dasatinib (nM) 0 0 0.5 1 5 10 M-CSF - + + + + + B WB: Phospho- FMSY708 WB: FMS C D 200 Dasatinib (nM ) 0 0 0.1 0.5 1 5 M-CSF - + + + + + 160 Side scatter Cell event count 120 Wb: Phospho-Akt Akt 80 40 0 250K 200K 50K 100K 150K 0 0 102 103 104 105 Forward scatter CD14- FITC Figure S1 A Dasatinib (nM ) 0 0 0.1 0.5 1 5 M-CSF - + + + + + WB: Phospho-Erk WB: Erk WB: Phospho-Akt WB: Akt

  2. G H 120 120 100 E 100 80 80 % macrophage survival TAM per mm2 60 60 40 40 20 20 1 F 0 0.5 No M-CSF 0 0.5 1 Imatinib (μM) Imatinib (μM) J I

More Related